Powered by Patented IP
Three platforms converge to solve complex issues with multiple data types.
Massive Analytic's patented technology, Artificial Precognition, delivers exceptional and explainable results, with incredible predictive accuracy in all tested use cases, all in the packaging of a general AI, not an overfit model. For example, predicting the early onset of Alzeihmers from blood biomarkers with 91% accuracy even in asymptomatic individuals.
This technology is offered in integrated, versatile AI suites built around all users, not just data scientists. With rich features to tackle the most difficult data challenges and support decisions that drive revenue, increase productivity and reduce risk.
Not one but three integrated AI suites
Together they Enable us to...
...improve predictive accuracy
...lower the cost of modelling
...provide 'explainable' AI as a Service
...shorten the time from modelling to operations
...enpower enterprise wide collaboration
Case Study: Identifying Cancer Cells with Machine Learning Using Oscar
The early diagnosis and prognosis of a cancer type has become a necessity in cancer treatment. Massive Analytic Limited developed new algorithms for use in precision medicine for personalised treatment of cancer victims.